Sustained Release Formulation Comprising Octreotide And Two Or More Polylactide-Co-Glycolide Polymers

Patent No. EP1968549 (titled "Sustained Release Formulation Comprising Octreotide And Two Or More Polylactide-Co-Glycolide Polymers") was filed by Novartis on Dec 20, 2006. The application was issued on May 14, 2014.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UK TRADING MYLANFeb 16, 2015COOKE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1968549

NOVARTIS
Application Number
EP06841059A
Filing Date
Dec 20, 2006
Status
Opposition Rejected
Nov 11, 2016
Publication Date
May 14, 2014